{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:12:16Z","timestamp":1778767936784,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.endien.2026.501721","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:29:58Z","timestamp":1778765398000},"page":"501721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum miR-21 and miR-192 levels in type 2 diabetes: Association with albuminuria and renal function"],"prefix":"10.1016","volume":"73","author":[{"given":"Nosaiba M.","family":"Abd Alrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alshaymaa A.","family":"Abd Elalim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enas A.","family":"Farrag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimaa M.","family":"Abdel-Kareem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar SaadEldeen","family":"Shaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya A.","family":"Eldamanhory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sammar Ahmed","family":"Kasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radwa M.","family":"Fath Allah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma I.","family":"Mayah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya A.","family":"Ghamry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabah M.","family":"Alkhawagah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad Gamil","family":"Khidr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2026.501721_bib0200","doi-asserted-by":"crossref","DOI":"10.1177\/14791641211058856","article-title":"Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: a review of the literature","volume":"18","author":"Thipsawat","year":"2021","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.endien.2026.501721_bib0205","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3390\/life12081202","article-title":"Up-date on diabetic nephropathy","volume":"12","author":"Pelle","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.endien.2026.501721_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.endien.2026.501721_bib0215","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US renal data system 2020 annual data report: epidemiology of kidney disease in the United States","volume":"77","author":"Johansen","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.endien.2026.501721_bib0220","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1523-1755.2004.00925.x","article-title":"Progression of nephropathy in type 2 diabetic patients","volume":"66","author":"Rossing","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.endien.2026.501721_bib0225","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ncrna.2023.08.009","article-title":"The function of miRNAs in the process of kidney development","volume":"8","author":"Sun","year":"2023","journal-title":"Non-coding RNA Res"},{"key":"10.1016\/j.endien.2026.501721_bib0230","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1179161","article-title":"Roles of microRNA-192 in diabetic nephropathy: the clinical applications and mechanisms of action","volume":"14","author":"Wan","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.endien.2026.501721_bib0235","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s43042-024-00544-z","article-title":"Evaluation of serum MicroRNA 21, MicroRNA 192 and serum TGF\u03b21 in type 2 diabetes mellitus patients and their relation to diabetic nephropathy","volume":"25","author":"Abou Eleila","year":"2024","journal-title":"Egypt J Med Hum Genet"},{"issue":"Suppl. 1","key":"10.1016\/j.endien.2026.501721_bib0240","first-page":"S27","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2026.501721_bib0245","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine-and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endien.2026.501721_bib0250","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.endien.2026.501721_bib0255","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1681\/ASN.2014070665","article-title":"Diabetes induces aberrant DNA methylation in the proximal tubules of the kidney","volume":"26","author":"Marumo","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl. 1","key":"10.1016\/j.endien.2026.501721_bib0260","first-page":"S69","article-title":"Diabetic nephropathy","volume":"23","author":"Association","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2026.501721_bib0265","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.ki.5002180","article-title":"Phenotypic transitions and fibrosis in diabetic nephropathy","volume":"71","author":"Simonson","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.endien.2026.501721_bib0270","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8719060","article-title":"The role of MicroRNAs in the pathogenesis of diabetic nephropathy","volume":"2019","author":"Tang","year":"2019","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.endien.2026.501721_bib0275","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ki.2011.43","article-title":"A microRNA circuit mediates transforming growth factor-\u03b21 autoregulation in renal glomerular mesangial cells","volume":"80","author":"Kato","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.endien.2026.501721_bib0280","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1681\/ASN.2011050485","article-title":"Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy","volume":"23","author":"Putta","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.endien.2026.501721_bib0285","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2337\/db09-1736","article-title":"E-cadherin expression is regulated by miR-192\/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-\u03b2","volume":"59","author":"Wang","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.endien.2026.501721_bib0290","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12013-013-9539-2","article-title":"Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice","volume":"67","author":"Wang","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.endien.2026.501721_bib0295","doi-asserted-by":"crossref","DOI":"10.1177\/20543581241260948","article-title":"The correlation of microRNA-21 with the nephrin, podocin, and urinary albumin-creatinine ratio in patients with type 2 diabetes and albuminuria: a cross-sectional study","volume":"11","author":"Nugroho","year":"2024","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.endien.2026.501721_bib0300","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2147\/DDDT.S170840","article-title":"Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice","author":"Wang","year":"2018","journal-title":"Drug Des Dev Therapy"},{"key":"10.1016\/j.endien.2026.501721_bib0305","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1681\/ASN.2010121308","article-title":"TGF-\u03b2\/Smad3 signaling promotes renal fibrosis by inhibiting miR-29","volume":"22","author":"Qin","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.endien.2026.501721_bib0310","doi-asserted-by":"crossref","first-page":"457","DOI":"10.7150\/ijms.15548","article-title":"Differential microRNA profiles predict diabetic nephropathy progression in Taiwan","volume":"13","author":"Chien","year":"2016","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.endien.2026.501721_bib0315","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ncpendmet0894","article-title":"The pathogenesis of diabetic nephropathy","volume":"4","author":"Dronavalli","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501721_bib0320","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1681\/ASN.2009050530","article-title":"Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy","volume":"21","author":"Krupa","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.endien.2026.501721_bib0325","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcjd.2013.07.003","article-title":"MicroRNAs: the underlying mediators of pathogenetic processes in vascular complications of diabetes","volume":"37","author":"Ruiz","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.endien.2026.501721_bib0330","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5603\/DK.2020.0045","article-title":"Plasma microRNA-192 expression as a potential biomarker of diabetic kidney disease in patients with type 2 diabetes mellitus","volume":"9","author":"Abdelaty","year":"2020","journal-title":"Clin Diabetol"},{"key":"10.1016\/j.endien.2026.501721_bib0335","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/ejim.ejim_89_18","article-title":"Evaluation of microRNA-192 in patients with diabetic nephropathy","volume":"31","author":"Saadi","year":"2019","journal-title":"Egypt J Int Med"},{"key":"10.1016\/j.endien.2026.501721_bib0340","first-page":"1171","article-title":"Expression of microRNA-377 and microRNA-192 and their potential as blood-based biomarkers for early detection of type 2 diabetic nephropathy","volume":"18","author":"Al-Kafaji","year":"2018","journal-title":"Molec Med Rep"},{"key":"10.1016\/j.endien.2026.501721_bib0345","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.3390\/ijms21072632","article-title":"Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities","volume":"21","author":"Opazo-R\u00edos","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.endien.2026.501721_bib0350","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3233\/NHA-160020","article-title":"MicroRNA 21 is up-regulated in adipose tissue of obese diabetic subjects","volume":"4","author":"Guglielmi","year":"2017","journal-title":"Nutr Healthy Aging"},{"key":"10.1016\/j.endien.2026.501721_bib0355","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jcp.22716","article-title":"MicroRNA 21 regulates the proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat diet-induced obesity alters microRNA 21 expression in white adipose tissues","volume":"227","author":"Kim","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.endien.2026.501721_bib0360","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003205","article-title":"MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways","volume":"4","author":"Chau","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.endien.2026.501721_bib0365","doi-asserted-by":"crossref","first-page":"25586","DOI":"10.1074\/jbc.M110.208066","article-title":"MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes","volume":"286","author":"Dey","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.endien.2026.501721_bib0370","article-title":"MicroRNA-21: a critical pathogenic factor of diabetic nephropathy","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.endien.2026.501721_bib0375","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/ijn.IJN_80_19","article-title":"MicroRNA-21 as an early marker of nephropathy in patients with type 1 diabetes","volume":"30","author":"Fouad","year":"2020","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.endien.2026.501721_bib0380","doi-asserted-by":"crossref","first-page":"17737","DOI":"10.1038\/s41598-017-18175-3","article-title":"Urinary miR-21 as a potential biomarker of hypertensive kidney injury and fibrosis","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.endien.2026.501721_bib0385","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.xkme.2020.11.009","article-title":"Kidney microRNA-21 expression and kidney function in IgA nephropathy","volume":"3","author":"Szeto","year":"2021","journal-title":"Kidney Med"},{"key":"10.1016\/j.endien.2026.501721_bib0390","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.3390\/ijms21186547","article-title":"MicroRNAs in chronic kidney disease: four candidates for clinical application","volume":"21","author":"Peters","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018026000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018026000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:30:03Z","timestamp":1778765403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018026000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2530018026000879"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2026.501721","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum miR-21 and miR-192 levels in type 2 diabetes: Association with albuminuria and renal function","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2026.501721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501721"}}